Apollo Biotech

RESEARCH USE ONLY: These products are strictly for laboratory research purposes and not for human consumption.

Back to Knowledge Base

Sermorelin

Growth Hormone-Releasing Hormone (GHRH) Analogue

Peptide Profile

Sequence

YADAIFTNSYRKVLGQLSARKLLQDIMSR

Molecular Weight

3357.9 g/mol

Storage Requirements

For maximum stability, store the lyophilized powder at -20°C (or -80°C for long-term preservation) protected from light and moisture. Once reconstituted with bacteriostatic water or sterile saline, the solution should be kept refrigerated at 2°C to 8°C and utilized within 14–21 days. Avoid repeated freeze-thaw cycles and keep vials tightly sealed until use to maintain compound integrity.

Relevant Literature

Recent in-vitro studies:

Selected in-vitro / cell-based PubMed literature relevant to this compound:

  1. Reference 1

    P Gaudreau et al. (1992). Affinity of human growth hormone-releasing factor (1-29)NH2 analogues for GRF binding sites in rat adenopituitary. J Med Chem. PMID: 1534126.

    View on PubMed
  2. Reference 2

    P Esposito et al. (2003). PEGylation of growth hormone-releasing hormone (GRF) enhances biological activity in vivo and in vitro. J Control Release. PMID: 14499707.

    View on PubMed
  3. Reference 3

    A Knoop et al. (2016). Qualitative identification of growth hormone-releasing hormones in human plasma by means of immunoaffinity purification and LC-HRMS/MS. Drug Test Anal. PMID: 26879649.

    View on PubMed